• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空腹血糖受损和体重指数作为抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中死亡率的决定因素:肥胖悖论是否真实存在?

Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real?

作者信息

Shah Ravi V, Abbasi Siddique A, Yamal José-Miguel, Davis Barry R, Barzilay Joshua, Einhorn Paula T, Goldfine Alison B

机构信息

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.

出版信息

J Clin Hypertens (Greenwich). 2014 Jun;16(6):451-8. doi: 10.1111/jch.12325. Epub 2014 Apr 29.

DOI:10.1111/jch.12325
PMID:24779706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4091725/
Abstract

Emerging literature suggests that obesity may be "protective" against mortality and cardiovascular outcomes, while dysglycemia may worsen outcomes regardless of obesity. The authors measured the association of weight, smoking, and glycemia with mortality in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Among 5423 ALLHAT participants without established diabetes or cardiovascular disease, 3980 (73%) had normal fasting glucose and 1443 (27%) had impaired fasting glucose (IFG) levels at study entry. After a median of 4.9 years follow-up, 554 (10%) had died (37% cardiovascular). IFG was associated with higher all-cause mortality (adjusted hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.02-1.50), while obesity was associated with lower all-cause mortality (adjusted HR, 0.76; 95% CI, 0.60-0.96). However, after excluding underweight individuals (body mass index [BMI] <22 kg/m(2) ) and smokers, neither obesity nor IFG was associated with all-cause mortality [corrected]. Although obesity appeared protective against mortality, this association was not significant in never-smokers or after exclusion of BMI <22 kg/m(2) . The obesity paradox may result from confounding by a sicker, underweight referent population and smoking.

摘要

新出现的文献表明,肥胖可能对死亡率和心血管疾病结局具有“保护作用”,而血糖异常可能会使结局恶化,无论是否肥胖。作者在抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中测量了体重、吸烟和血糖与死亡率之间的关联。在5423名无糖尿病或心血管疾病病史的ALLHAT参与者中,3980名(73%)在研究开始时空腹血糖正常,1443名(27%)空腹血糖受损(IFG)。经过中位数4.9年的随访,554名(10%)死亡(37%为心血管疾病死亡)。IFG与全因死亡率较高相关(调整后风险比[HR],1.23;95%置信区间[CI],1.02 - 1.50),而肥胖与全因死亡率较低相关(调整后HR,0.76;95%CI,0.60 - 0.96)。然而,在排除体重过轻个体(体重指数[BMI]<22 kg/m²)和吸烟者后,肥胖和IFG均与全因死亡率无关[校正后]。尽管肥胖似乎对死亡率有保护作用,但这种关联在从不吸烟者中或排除BMI<22 kg/m²后并不显著。肥胖悖论可能是由于病情较重、体重过轻的参照人群和吸烟造成的混杂所致。

相似文献

1
Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real?空腹血糖受损和体重指数作为抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中死亡率的决定因素:肥胖悖论是否真实存在?
J Clin Hypertens (Greenwich). 2014 Jun;16(6):451-8. doi: 10.1111/jch.12325. Epub 2014 Apr 29.
2
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.糖耐量和 BMI 对健康人群心血管事件和全因死亡率的协同作用:CA.ME.LI.A 研究 7 年随访结果
Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E498-E511. doi: 10.1152/ajpendo.00181.2024. Epub 2024 Aug 28.
3
Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.血糖异常与长期死亡率:来自以色列葡萄糖耐量异常、肥胖和高血压研究的观察结果。
Diabetes Metab Res Rev. 2015 May;31(4):368-75. doi: 10.1002/dmrr.2618. Epub 2014 Dec 12.
4
Obesity Paradox and the Effect of NT-proBNP on All-Cause and Cause-Specific Mortality.肥胖悖论与 NT-proBNP 对全因和死因特异性死亡率的影响。
Clin Cardiol. 2024 Nov;47(11):e70044. doi: 10.1002/clc.70044.
5
Association between Body Mass Index and All-Cause Mortality in Hypertensive Adults: Results from the China Stroke Primary Prevention Trial (CSPPT).高血压成年人的体重指数与全因死亡率之间的关联:中国脑卒中一级预防试验(CSPPT)的结果
Nutrients. 2016 Jun 22;8(6):384. doi: 10.3390/nu8060384.
6
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).随机接受3种不同类别降压治疗的老年非糖尿病成年人的空腹血糖水平与新发糖尿病:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)的报告
Arch Intern Med. 2006 Nov 13;166(20):2191-201. doi: 10.1001/archinte.166.20.2191.
7
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT.在抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中,使用三种不同抗高血压药物治疗的正常体重、超重和肥胖高血压患者的血压控制及心血管结局
J Hypertens. 2014 Jul;32(7):1503-13; discussion 1513. doi: 10.1097/HJH.0000000000000204.
8
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).2型糖尿病、空腹血糖受损及血糖正常者降压治疗的临床结局:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)
Arch Intern Med. 2005 Jun 27;165(12):1401-9. doi: 10.1001/archinte.165.12.1401.
9
Obesity, smoking habits, and serum phosphate levels predicts mortality after life-style intervention.肥胖、吸烟习惯和血清磷酸盐水平预测生活方式干预后的死亡率。
PLoS One. 2020 Jan 16;15(1):e0227692. doi: 10.1371/journal.pone.0227692. eCollection 2020.
10
The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.空腹血糖变化对心肌梗死、卒中和全因死亡率风险的影响:一项全国性队列研究。
Cardiovasc Diabetol. 2018 Apr 7;17(1):51. doi: 10.1186/s12933-018-0694-z.

引用本文的文献

1
Is Targeting LDL-C Levels Below 70 mg/dL Beneficial for Cardiovascular and Overall Health? A Critical Examination of the Evidence.将低密度脂蛋白胆固醇(LDL-C)水平降至70mg/dL以下对心血管和整体健康有益吗?对证据的批判性审视。
J Clin Med. 2025 May 20;14(10):3569. doi: 10.3390/jcm14103569.
2
Association between the triglyceride glucose index and short-term mortality in septic patients with or without obesity: a retrospective cohort study.脂联素葡萄糖指数与肥胖或非肥胖脓毒症患者短期死亡率的关系:一项回顾性队列研究。
Adipocyte. 2024 Dec;13(1):2379867. doi: 10.1080/21623945.2024.2379867. Epub 2024 Jul 16.
3
Association between obesity and neurological outcomes among out-of-hospital cardiac arrest patients: The SOS-KANTO 2017 study.院外心脏骤停患者肥胖与神经学预后的关联:SOS-KANTO 2017研究
Resusc Plus. 2023 Nov 23;17:100513. doi: 10.1016/j.resplu.2023.100513. eCollection 2024 Mar.
4
In-Hospital Outcomes of Coronary Artery Stenting in Patients With ST-Elevation Myocardial Infarction (STEMI) and Metabolic Syndrome: Insights From the National Inpatient Sample.ST段抬高型心肌梗死(STEMI)合并代谢综合征患者冠状动脉支架置入术的院内结局:来自全国住院患者样本的见解
Cureus. 2022 May 2;14(5):e24664. doi: 10.7759/cureus.24664. eCollection 2022 May.
5
Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.系统评估心力衰竭风险预测工具:预防心力衰竭的 pooled cohort equations。
PLoS One. 2020 Nov 3;15(11):e0240567. doi: 10.1371/journal.pone.0240567. eCollection 2020.
6
Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose-response meta-analysis.体重指数与射血分数正常和降低的心衰患者的全因死亡率:剂量反应荟萃分析。
Clin Res Cardiol. 2019 Feb;108(2):119-132. doi: 10.1007/s00392-018-1302-7. Epub 2018 Jun 27.
7
Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.褪黑素在肥胖和高血压中的抗炎作用。
Curr Hypertens Rep. 2018 May 9;20(5):45. doi: 10.1007/s11906-018-0842-6.
8
Obesity is bad regardless of the obesity paradox for hypertension and heart disease.无论肥胖与高血压和心脏病之间存在何种肥胖悖论,肥胖都是有害的。
J Clin Hypertens (Greenwich). 2018 May;20(5):842-846. doi: 10.1111/jch.13281. Epub 2018 Apr 17.
9
The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.肥胖与高血压的关系:关于恶性双胞胎的最新综合概述。
Hypertens Res. 2017 Dec;40(12):947-963. doi: 10.1038/hr.2017.75. Epub 2017 Oct 5.
10
The obesity paradox: is it really a paradox? Hypertension.肥胖悖论:它真的是一个悖论吗?高血压。
Eat Weight Disord. 2017 Mar;22(1):43-48. doi: 10.1007/s40519-016-0330-4. Epub 2016 Nov 4.

本文引用的文献

1
Body-mass index and mortality among adults with incident type 2 diabetes.成人 2 型糖尿病患者的体重指数与死亡率。
N Engl J Med. 2014 Jan 16;370(3):233-44. doi: 10.1056/NEJMoa1304501.
2
Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality.体脂分布与心血管疾病、癌症的发生及全因死亡率。
J Am Coll Cardiol. 2013 Sep 3;62(10):921-5. doi: 10.1016/j.jacc.2013.06.027. Epub 2013 Jul 10.
3
Overweight, obesity, and all-cause mortality--reply.超重、肥胖与全因死亡率——回复
JAMA. 2013 Apr 24;309(16):1681-2. doi: 10.1001/jama.2013.3101.
4
Overweight, obesity, and all-cause mortality.超重、肥胖与全因死亡率
JAMA. 2013 Apr 24;309(16):1681. doi: 10.1001/jama.2013.3075.
5
Does body mass index adequately convey a patient's mortality risk?体重指数能否充分反映患者的死亡风险?
JAMA. 2013 Jan 2;309(1):87-8. doi: 10.1001/jama.2012.185445.
6
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.《2013年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
7
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.体型和降压治疗对心血管事件发生率的影响:ACCOMPLISH 随机对照试验的亚组分析。
Lancet. 2013 Feb 16;381(9866):537-45. doi: 10.1016/S0140-6736(12)61343-9. Epub 2012 Dec 6.
8
Association of weight status with mortality in adults with incident diabetes.体重状况与新发糖尿病成人死亡率的相关性。
JAMA. 2012 Aug 8;308(6):581-90. doi: 10.1001/jama.2012.9282.
9
Secular declines in the association between obesity and mortality in the United States.美国肥胖与死亡率之间关联的长期下降。
Popul Dev Rev. 2011;37(3):435-51. doi: 10.1111/j.1728-4457.2011.00429.x.
10
Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).空腹血糖受损与成年人发生糖尿病和心血管事件的风险:MESA(动脉粥样硬化的多民族研究)。
J Am Coll Cardiol. 2011 Jul 5;58(2):140-6. doi: 10.1016/j.jacc.2011.03.025.